Professor of Medicine and Therapeutics and Director, Hong Kong Institute of Diabetes and Obesity at the Chinese University of Hong Kong, Professor Chan is a clinician scientist committed to translating evidence to practice and developing novel solutions for unmet needs. In the early 1990s, she set up the Hong Kong Diabetes Register and multiple cohorts to define the epidemiology of diabetes in Chinese populations. She is currently a member of an NIH-funded Global Consortium to discover causal genes in type 2 diabetes in a multi-ethnic population.
As one of the first Asian investigators involved in large scale multicenter studies in diabetes since 1990s, she established the CUHK Diabetes Clinical Trial Centre to implement a large number of landmark studies, pragmatic trials and epidemiological surveys. She is a steering committee member of multicenter clinical trials including the ORIENT, EASIE, EXSCEL, ACE, FIDELIO, FIGARO which evaluate the effects of novel compounds on clinical outcomes in diabetes. She founded the Asia Diabetes Foundation to develop the first web-based Joint Asia Diabetes Evaluation (JADE) Program which uses logistics, collaborative care, and information technology to promote quality improvement and collaborative research, now implemented in 11 Asian countries.